Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. (Q47899170)

6 February 2018

title

Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. (English)

1 reference

6 February 2018

0 references

0 references

4

1 reference

6 February 2018

author name string

Richard Kraemer

1

1 reference

6 February 2018

Andrea Blum

2

1 reference

6 February 2018

Andreas Schibler

3

1 reference

6 February 2018

Sabina Gallati

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

5 November 2004

1 reference

6 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

6 February 2018

volume

171

1 reference

6 February 2018

issue

4

1 reference

6 February 2018

page(s)

371-378

1 reference

6 February 2018

Determinants of mortality from cystic fibrosis in Canada, 1970-1989.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Genotype-phenotype correlations in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

The age at onset of chronic Pseudomonas aeruginosa colonization in cystic fibrosis--prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Modern statistical techniques for the analysis of longitudinal data in biomedical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

The effect of postrehabilitation programmes among individuals with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

The diagnosis of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Infection control in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Intrapulmonary gas distribution in healthy children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Multiple-breath nitrogen washout techniques: including measurements with patients on ventilators

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Total lung capacity by N2 washout from high and low lung volumes in ventilated infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

The open circuit nitrogen washout technique for measuring the lung volume in infants: methodological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Combined body plethysmographic, spirometric and flow volume reference values for male and female children aged 6 to 16 years obtained from "hospital normals".

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

The decline and fall of pulmonary function in cystic fibrosis: new models, new lessons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Effect of choice of reference equation on analysis of pulmonary function in cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Detecting early structural lung damage in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Risk of death in cystic fibrosis patients with severely compromised lung function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Wisconsin cystic fibrosis chest radiograph scoring system: validation and standardization for application to longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Survival effect of lung transplantation among patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Early airway infection, inflammation, and lung function in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Survival rates in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

Predictive 5-year survivorship model of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200407-948OC

10.1164/RCCM.200407-948OC

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

15531750

1 reference

6 February 2018